The American Academy of Pediatrics (AAP) issued new guidelines recommending aggressive early intervention for childhood obesity, including weight loss medications and bariatric surgery for children as young as 12 and 13. Critics argue that these recommendations ignore the role of highly processed foods and the "food pyramid" in the obesity crisis. The rise of drugs like Ozempic is highlighted as part of a growing pharmaceutical trend to treat obesity as a chronic disease rather than a dietary issue.
